Condition

Hepotacellular Carcinoma clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• AI-guided personalized pre- and post-surgery treatment to reduce liver cancer recurrence

  This will try using an AI tool to pick early-stage hepatocellular carcinoma patients at high risk of recurrence and give them medication before and after surgery to see if it reduces the chance the cancer comes back within two years.

  Recruiting Phase 1/2 Tongji Hospital · Wuhan, Hubei · NCT07282184

• Serum AKR1B10 as an early-warning marker for hepatocellular carcinoma in cirrhosis

  This study will test whether a blood test for AKR1B10 can help detect early liver cancer in adults with cirrhosis.

  Recruiting The First Affiliated Hospital of University of South China · Hengyang, Hunan · NCT07147335

Related topics

Quick answers

How many Hepotacellular Carcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →